相关实验视频

Updated: May 25, 2025

Transplantation of Induced Pluripotent Stem Cell-derived Mesoangioblast-like Myogenic Progenitors in Mouse Models of Muscle Regeneration

Transplantation of Induced Pluripotent Stem Cell-derived Mesoangioblast-like Myogenic Progenitors in Mouse Models of Muscle Regeneration

Published on: January 20, 2014

人类iPSC衍生肌肉细胞作为研究EDMD1病变的新模型

Marta Lisowska¹, Marta Rowińska¹, Aleksandra Suszyńska¹

¹Laboratory of Nuclear Proteins, Faculty of Biotechnology, University of Wrocław, 50-383 Wrocław, Poland.

International journal of molecular sciences

|February 26, 2025

概括

研究人员从Emery-Dreifuss肌肉衰竭1型 (EDMD1) 患者中制造了诱导多能干细胞 (iPSC). 这种人类细胞模型有助于研究EDMD1疾病机制,并开发新疗法.

科学领域:

生物化学生物化学
遗传学是一个遗传学.
细胞生物学细胞生物学

背景情况:

埃梅里-德莱法斯肌肉衰竭1型 (EDMD1) 是一种罕见的遗传疾病,由EMD基因的突变引起,影响核蛋白质emerin.
驱动EDMD1肌肉和心脏病理的精确分子机制尚未完全理解.
患者获得的样本数量有限阻碍了研究,需要开发人体特异性的细胞模型.

研究的目的:

从具有EMD突变的EDMD1患者中生成和表征诱导多能干细胞 (iPSC) 线.
建立一个人体特异性的体外模型,用于研究肌肉发育过程中的EDMD1病原体.
为研究疾病机制和开发针对EDMD1.1的向治疗提供一个平台.

主要方法:

从EDMD1患者和健康捐赠者生成iPSC线.
对iPSCs进行多能性,型稳定性和差异化潜力的表征.
患者衍生的iPSCs分化为肌原原体,肌细胞和肌管,以建模肌生成.

主要成果:

来自患者的iPSC显示出稳定的肉类型,适当的形态,多能性标记物表达和三线分化能力.
分化细胞成功地重复了肌体发生的关键阶段,并通过特定阶段的标志物进行验证.
该研究成功建立了第一个基于iPSC的体外平台,用于建模EDMD1的病原性.

结论:

开发的iPSC模型准确地代表了肌形成过程中的EDMD1病理.
这个平台为阐明疾病机制提供了有价值的工具.
该模型具有很大的潜力,可以推进针对EDMD1.1的向治疗策略的开发.

关键词:

这是EMD突变.埃梅里·德里弗斯 (EmeryDreifuss) 肌肉发育不良症疾病建模疾病建模埃默林 (Emerin) 是一个非常重要的.肌肉的分化在试验室内进行了实验.这是骨肌肉.干细胞是干细胞的组成部分.

更多相关视频

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells

Published on: July 29, 2016

CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors

CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors

Published on: September 14, 2019

相关概念视频

EPS and iPS Cells in Disease Research

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...

Satellite Stem Cells and Muscular Dystrophy

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...